Proactive Investors - Run By Investors For Investors

Ted Baker out of fashion as Barclays says future growth already baked in

“We find it difficult to see upside potential from current valuation levels, given limited catalysts and the longer-term risks we have discussed”
ted baker advert
Nothing to see here, according to Barclays

Shares in Ted Baker PLC (LON:TED) were up for sale on Wednesday after Barclays kicked off coverage of the fashion label with a fairly lethargic research note.

The investment banking arm of the London bank said the current valuation was “fair” with all the upside and downside risks already baked in as it initiated with an ‘equal weight’ rating and £27 target price.

READ: Ted Baker shrugs of retail market challenges to report revenue growth

Analyst Boris Vilidnitsky praised Ted’s “strong growth profile”, stable margins and recent investment into its online offering but admitted he had “significant” concerns about long product lead times compared to its peers and how licensing deals with tile and plate makers might “reduce credibility” in its core premium fashion category.

For all that, the analyst doesn’t expect any of those points to impact the share price, positively or negatively, any time soon.

“The risks mentioned above, although significant, are unlikely to materialize or impact the share price in the near term, in our view,” wrote Vilidnitsky in a note on Wednesday.

“At the same time, we believe that the positives are well-understood and unlikely to be major catalysts.”

Vilidnitsky notes that other premium names such as Hugo Boss and Burberry Group PLC (LON:BRBY) are comparatively cheaper based on predicted earnings per share, although he does feel that Ted justifies its premium because of its strong brand.

That said, he still adds: “We find it difficult to see upside potential from current valuation levels, given limited catalysts and the longer-term risks we have discussed.”

Shares fell 2.1% to £25.39 on Wednesday morning.

View full TED profile View Profile

Ted Baker Timeline

Related Articles

Scans and MRI
November 28 2018
The firm's subsidiary, Imaging Biometrics, recently appointed a South Korean distributor a few weeks after receiving the first commercial order for its StoneChecker technology
H&T
December 03 2018
“I think customers are seeing that we do offer value and that really is the answer,” said chief executive John Nichols

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use